Should All Research Subjects Be Treated the Same?
One of the founding principles of research ethics is that subjects should be treated equally. In the words of the Belmont Report, 'equals ought to be treated equally.' This principle does not imply that all subjects should be treated exactly the same. Rather, subjects who are similar in relevant res...
| Publicado en: | Hastings Center Report Vol. 45; no. 1; pp. 17 - 21 |
|---|---|
| Autores principales: | , , |
| Formato: | Artículo |
| Publicado: |
Wiley-Blackwell
Jan2015
|
| Materias: | |
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ssf&AN=100491648&site=ehost-live header: @attributes: shortDbName: ssf uiTerm: 100491648 longDbName: Social Sciences Full Text (H.W. Wilson) uiTag: AN controlInfo: bkinfo: jinfo: jid: 00930334 HCR jtl: Hastings Center Report issn: 00930334 maglogo: Y pubinfo: dt: Jan2015 vid: 45 iid: 1 pid: 480 pub: Wiley-Blackwell artinfo: ui: 100491648 10.1002/hast.414 ppf: 17 ppct: 4 formats: fmt: – @attributes: type: T – @attributes: type: P size: 166KB tig: atl: Should All Research Subjects Be Treated the Same? aug: au: Brody, Baruch Migueles, Stephen A. Wendler, David su: Medical ethics Patient compliance Research ethics Resource allocation Human research subjects Hemapheresis HIV infections Vaccines sug: subj: Medical ethics Patient compliance Research ethics Resource allocation Human research subjects Pharmaceutical and medicine manufacturing Drugs and Druggists' Sundries Merchant Wholesalers Hemapheresis HIV infections Vaccines ab: One of the founding principles of research ethics is that subjects should be treated equally. In the words of the Belmont Report, 'equals ought to be treated equally.' This principle does not imply that all subjects should be treated exactly the same. Rather, subjects who are similar in relevant respects should receive similar treatment. Clinical status is clearly relevant to determining how subjects should be treated. Greater resources should be devoted to subjects who have worse diseases. In contrast, fame is irrelevant. Subjects should not receive greater resources simply because they are famous. A more challenging question, one that pervades clinical research yet has received almost no attention in the literature, is whether subjects' level of scientific importance is relevant to determining how much support they should receive.. pubtype: Academic Journal doctype: Article src: R language: English refInfo: copyright: @attributes: flag: N holdings: @attributes: islocal: N |
|---|